Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,735.00
-15.00 (-0.40%)
At close: Jun 18, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 30.53 billion as of June 18, 2026. Its market cap has decreased by -53.71% in one year.
Market Cap
30.53B
Enterprise Value
29.25B
Revenue
647.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
3,735.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 30.53B, a decrease of -74.24%. That is a compound annual growth rate of -23.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 30.53B | 9.19% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DRGEM | 55.79B |
| QuantaMatrix | 52.85B |
| JPI Healthcare | 41.05B |
| Genoray | 40.57B |
| Noul Co.,Ltd. | 37.03B |
| UXN Co., Ltd. | 34.13B |
| MEKICS CO., | 32.08B |
| CU Medical Systems | 23.19B |